CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 7,279 shares at $445.63 ($3,243,741)
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 7,616 shares at an average $400.18 ($3,047,756)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 97,065 shares at an average $380.58 ($36,941,197)
- 4 Open-market buy Director bought 68,618 shares at an average $364.04 ($24,979,827)
- 144 Insider Sale of Securities
- 4 Planned sale General Counsel sold 1,304 shares at an average $367.81 ($479,627)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 10,000 shares at an average $365.20 ($3,652,009)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 129,172 shares at an average $370.24 ($47,825,149)
Page 6 of 62 · 1,224 filings